9068 Results

Congress Abstract

Treatment outcomes of carcinoma buccal mucosa treated with definitive accelerated radiotherapy

Authors:

Cessal Thommachan Kainickal1, Geethu Babu2, Rejnish Ravi Kumar2, Malu Rafi1, Aparna M.P1, Lekha M Nair1, Farida N1, Preethi George3, Ramadas K4

1Regional Cancer Centre, Department of Radiation Oncology, Thiruvananthapuram, India; 2Regional Cancer Centre , Department of Radiation Oncology, Thiruvananthapuram, India; 3Regional Cancer Centre, Department of Cancer Epidemiology & Biostatistics, Thiruvananthapuram, India; 4Regional Cancer Centre, Department of Radiation Oncology, Thiruvananthapuram,, India

Show Affiliations

Journal Article

Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy

Authors: Alexander F. Bagley, Rong Ye, Adam S. Garden, Gary Brandon Gunn, David I. Rosenthal, Clifton David Fuller, William H. Morrison, Jack Phan, Erich M. Sturgis, Renata Ferrarotto, Richard Wu, Amy Y. Liu, Steven J. Frank

Congress Abstract

Influence of abdominal air cavities on the dose distribution of daily-adapted plans

Authors:

Francesca Belosi1, Marta Bogowicz1, Madalyne Chamberlain1, Stefanie Ehrbar1, Helena Garcia Schüler2, Jérôme Krayenbuehl2, Matthias Guckenberger3, Nicolaus Andratschke3, Stephanie Tanadini-Lang2, Lotte Wilke2

1University Hospital Zürich, Radiation Oncology, Zürich, Switzerland; 2University Hospital Zürich , Radiation Oncology, Zürich, Switzerland; 3University Hospital Zürich and University of Zürich, Radiation Oncology, Zürich, Switzerland

Show Affiliations

Congress Abstract

Radiographer-led online image guided adaptive radiotherapy: A qualitative investigation

Authors:

Elizabeth Joyce1, Helen A McNair1,2, Geraldine O'Gara3, Marcus Jackson4, Bianca Peet5, Robert A Huddart2, Theresa Wiseman3

1Royal Marsden Hospital, Radiotherapy, London, United Kingdom; 2Institute of Cancer Research, Radiotherapy and Imaging, London, United Kingdom; 3Royal Marsden Hospital, Health Research, London, United Kingdom; 4St George's University of London, Radiography, London, United Kingdom; 5Royal Marsden Hospital, Clinical Trials, London, United Kingdom

Show Affiliations

Congress Abstract

Real-world patient & treatment characteristics of oligometastatic disease: results of OligoCare

Authors:

Matthias Guckenberger1, Umberto Ricardi2, Marta Scorsetti3, Panagiotis Balermpas1, Yolande Lievens4, Filippo Alongi5, Lorenzo Livi6, Pètra Braam7, Barbara Alicja Jereczek-Fossa8, Karin Stellamans9, Luc Verbeke10, Heike Peulen11, Kaouthar Khanfir12, Sara Ramella13, Thomas Zilli14, Xavier Geets15, Hossein Hemmatazad16, Giovanni Battista Ivaldi17, Ivica Ratosa18, Paul Jeene19, Beatrice Fournier20, Catherine Fortpied20, Piet Ost4

1University Hospital Zürich, University of Zürich , Department of Radiation Oncology, Zürich, Switzerland; 2Università degli Studi di Torino, Radiation Oncology, Torino, Italy; 3Humanitas University, Pieve Emanuele (Milan), IRCCS Humanitas Research Hospital, Rozzano and Department of Biomedical Sciences, Milan, Italy; 4Universitair Ziekenhuis Gent, Radiation Oncology, Gent, Belgium; 5University of Brescia and IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Radiation Oncology, Negrar, Italy; 6Azienda Ospedaliero-Universitaria Careggi Florence, Radiation Oncology, Florence, Italy; 7Radboud University Medical Center Nijmegen, Radiation Oncology, Nijmegen, The Netherlands; 8University of Milan, Milan, Italy and Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Department of Oncology and Hemato-oncology, Milan, Italy; 9Campus Kennedylaan, AZ Groeninge Kortrijk , Kortrijk, Belgium; 10Onze-Lieve-Vrouw Ziekenhuis, Radiation Oncology, Aalst, Belgium; 11Catharina Ziekenhuis, Radiation Oncology, Eindhoven, The Netherlands; 12Hopital de Sion, Hopital du Valais , Sion, Switzerland; 13Universitario Campus Bio-Medico- Oncology Center, Policlinico , Roma, Italy; 14Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie, Radiation Oncology, Geneva, Switzerland; 15Cliniques Universitaires Saint-Luc, Radiation Oncology, Brussels, Belgium; 16Inselspital, Universitätsspital , Radiation Oncology, Bern, Switzerland; 17Istituti Clinici Scientifici Maugeri, Radiation Oncology, Pavia, Italy; 18Division of Radiation Oncology, Institute of Oncology , Ljubljana, Slovenia; 19Radiotherapiegroep, Deventer, the Netherlands, Radiotherapiegroep, Deventer, the Netherlands, Deventer, The Netherlands; 20European Organisation for Research and Treatment of Cancer (EORTC) , Headquarters, Brussels, Belgium

Show Affiliations

Journal Article

Tricks and tips for target volume definition and delineation in breast cancer: Lessons learned from ESTRO breast courses

Authors: Orit Kaidar-Person, Birgitte V. Offersen, Liesbeth Boersma, Icro Meattini, David Dodwell, Lynda Wyld, Marianne Aznar, Tibor Major, Thorsten Kuehn, Vratislav Strnad, Miika Palmu, Sandra Hol, Philip Poortmans

Journal Article

Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series

Authors: Qiaojuan Guo, Yahan Zheng, Jinyong Lin, Yun Xu, Cairong Hu, Jingfeng Zong, Tianzhu Lu, Hanchuan Xu, Bijuan Chen, Qiandong Liang, Youping Xiao, Jianji Pan, Shaojun Lin

Congress Abstract

Predictors of urinary incontinence 2 years after RT with different intents for prostate cancer

Authors:

Cesare Cozzarini1, Giuseppe Sanguineti2, Vittorio Vavassori3, Fernando Munoz4, Barbara Avuzzi5, Elisabetta Garibaldi6, Domenico Cante7, Justina Magdalena Waskiewicz8, Alessandro Magli9, Adriana Faiella10, Elisa Villa3, Letizia Ferella4, Marco Gatti11, Barbara Noris Chiorda5, Cristina Piva7, Paolo Ferrari12, Tiziana Rancati13, Fabio Badenchini13, Giuseppe Girelli14, Eugenia Moretti15, Riccardo Valdagni16, Andrea Bresolin17, Nadia Di Muzio18, Claudio Fiorino17

1San Raffaele Scientific Institute, Radiotherapy, Milan, Italy; 2IRCCS Istituto Nazionale dei Tumori “Regina Elena", Radiotherapy, Rome, Italy; 3Cliniche Gavazzeni Humanitas, Radiotherapy, Bergamo, Italy; 4Ospedale Regionale Parini-AUSL Valle d’Aosta, Radiotherapy, Aosta, Italy; 5Fondazione IRCCS Istituto Nazionale dei Tumori, Radiotherapy, Milan, Italy; 6A.O. SS. Antonio e Biagio, Radiotherapy, Radiotherapy, Alessandria, Italy; 7Ospedale di Ivrea, Radiotherapy, Ivrea, Italy; 8Azienda Sanitaria dell’Alto Adige, Radiotherapy, Bolzando, Italy; 9Azienda Ospedaliero Universitaria S. Maria della Misericordia, , Radiotherapy, Udine, Italy; 10IRCCS Istituto Nazionale dei Tumori “Regina Elena”, Radiotherapy, Rome, Italy; 11IRCC Candiolo, Radiotherapy, Candiolo, Italy; 12Azienda Sanitaria dell’Alto Adige, Radiotherapy, Bolzano, Italy; 13Fondazione IRCCS Istituto Nazionale dei Tumori - Prostate Program, Radiotherapy, Milan, Italy; 14Ospedale degli Infermi, Radiotherapy, Biella, Italy; 15Azienda Ospedaliero Universitaria S. Maria della Misericordia, Radiotherapy, Udine, Italy; 16Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Program - Università degli Studi Milano, Radiotherapy, Milan, Italy; 17San Raffaele Scientific Institute, Medical Physics, Milan, Italy; 18Università Vita Salute San Raffaele, Radiotherapy, Milan, Italy

Show Affiliations

Congress Abstract

'SBRT and the Boost', a love story: primary endpoint analysis of the phase II hypo-FLAME trial

Authors: Draulans|, Cédric(1,2)*[cedric_draulans@hotmail.com];van der Heide|, Uulke A.(3);Haustermans|, Karin(1,2);Pos|, Floris J.(3);van der Voort van Zyp|, Jochem(4);De Boer|, Hans(4);Groen|, Veerle(4);Monninkhof|, Evelyn M.(4,5);Smeenk|, Robert Jan(6);Kunze-Busch|, Martina(6);Depuydt|, Tom(1,2);De Roover|, Robin(1,2);Isebaert|, Sofie(1,2);Kerkmeijer|, Linda G.W.(4,6);
(1)University Hospitals Leuven, Department of Radiation Oncology, Leuven, Belgium;(2)KU Leuven, Department of Oncology, Leuven, Belgium;(3)The Netherlands Cancer Institute, Department of Radiation Oncology, Amsterdam, The Netherlands;(4)University Medical Centre Utrecht, Department of Radiation Oncology, Utrecht, The Netherlands;(5)University Medical Centre Utrecht, Julius Centre for Healthe Sciences and Primary Care, Utrecht, The Netherlands;(6)Radboud University Medical Centre, Department of Radiation Oncology, Nijmegen, The Netherlands;
Show Affiliations
*:*